Search Results 1271-1280 of 18956 for Neoplasm
For expansion part R/R iNHL cohort: Documented CD20+ mature B-cell neoplasm ... neoplastic agent(s):. At least 4 weeks from last dose of non-investigational ...
Receiving any other investigational agent which would be considered as a treatment for the primary neoplasm. Current inpatient hospitalization (excluding ...
... Neoplastic meningitis, Brainstem tumor, Leptomeningeal metastases, Diffuse glioma. Show more areas of focus for Maciej M. Mrugala, M.D., Ph.D. Research.
... Neoplastic meningitis, Diffuse glioma, Pilocytic astrocytoma, Plexiform neurofibroma, Diffuse midline glioma. Show more areas of focus for Maciej M. Mrugala ...
Transsphenoidal, sometimes called transsphenoidal surgery, is a procedure to remove tumors from the pituitary gland and nearby areas in the skull base. The ...
... Neoplastic meningitis, Leptomeningeal metastases, Diffuse glioma. Show more areas of focus for Maciej M. Mrugala, M.D., Ph.D. Research. Spinal cord tumor ...
... Neoplastic meningitis. Show more areas of focus for Maciej M. Mrugala, M.D., Ph.D. Pagination Doctor search. PrevPrevious Page · Go to page 11 · Go to page 22 ...
Subsequent malignant neoplasm (SMN) other than those listed below diagnosed ... neoplasms may be eligible if diagnosed within 2 years and all treatment ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.